Bisphenol A (BPA) and Di-(2-ethylhexyl) phthalate (DEHP) are two wide spread chemicals classified as endocrine disruptors (ED). The present study aims to estimate the non-dietary (dermal, non-dietary ingestion and inhalation) exposure to BPA and DEHP for a pregnant women cohort. In addition, to assess the prenatal exposure for the fetus, a physiologically based pharmacokinetic (PBPK) model was used. It was adapted for pregnancy in order to assess the internal dosimetry levels of EDs (BPA and DEHP) in the fetus. Estimates of exposure to BPA and DEHP from all pathways along with their relative importance were provided in order to establish which proportion of the total exposure came from diet and which came from non-dietary exposures. In this study, the different oral dosing scenarios (dietary and non-dietary) were considered keeping inhalation as a continuous exposure case. Total non-dietary mean values were 0.002 µg/kg bw /day (0.000; 0.004 µg/kg bw /day for 5th and 95th percentile, respectively) for BPA and 0.597 µg/kg bw /day (0.116 µg/kg bw /day and 1.506 µg/kg bw /day for 5th and 95th percentile, respectively) for DEHP. Indoor environments and especially dust ingestion were the main non-dietary contributors to the total exposure of BPA and DEHP with 60% and 81%. However, as expected, diet showed the higher contribution to total exposure with > 99.9% for BPA and 63% for DEHP. Although diet was considered the primary source of exposure to BPA and phthalates, it must be taken into account that with non-dietary sources the first-pass metabolism is lacking, so these may be of equal or even higher toxicological relevance than dietary sources.
Introduction
Bisphenol A (BPA) and Di-(2-ethylhexyl) phthalate (DEHP) are two high volume industrial chemicals used in a wide variety of consumer products. These compounds are defined as non-persistent Endocrine Disrupters (EDs) and are categorized as chemicals of concern by the World Health Organization (WHO, 2010) . The exposure to EDs plays a key role in the epigenome shaping of many aspects of the endocrine function (Casati, 2013; Chen et al., 2018) . The evidences present in the literature indicate that EDs can affect the different levels of epigenetic control and in some cases can act transgenerationally, if the exposure to EDs occurs during "critical windows of exposure", especially, the prenatal and the early life period (Sharma et al., 2016; Volle et al., 2015; Watkins et al., 2017) . Furthermore, some studies have shown that exposure to these chemicals in the early period of life may cause functional impairment of development and reproduction (Dodson et al., 2012; Meeker, 2012; Sakhi et al., 2014) , increase the risk of allergy/asthma (Robinson and Miller, 2015; Sakhi et al., 2014) and also can develop obesity and type 2 diabetes (Casas et al., 2011; De Cock et al., 2014; Myridakis et al., 2016) . It is known that fetal exposure is directly related to the mother's exposure, due to a bi-directional transfer of chemicals between the placenta and fetal plasma (Sharma et al., 2018) . Normally placental barrier is considered protective layer against harmful compounds, however, a recent study has found poor barrier mechanism of placenta against some common EDs (Go et al., 2007; Li et al., 2013; Ribeiro et al., 2017) .
Phthalates such as DEHP are industrial chemicals, which are used in polyvinyl chloride (PVC) plastics, found in products such as shoes, gloves and packing materials as well as in building materials, floorings and wall coverings (Giovanoulis et al., 2018) . In addition, they are used in pharmaceuticals products, personal care products (PCPs), paints and adhesives (Bao et al., 2015) . All of these applications are related to dermal contact, non-dietary ingestion or inhalation exposure sources. Some studies confirm that DEHP is an important contaminant in dust household; people can be exposed to it via dust ingestion, the exposure through this will be higher for workers in PVC industries (Fromme et al., 2004) . It is known that babies and young children are the most vulnerable groups with respect to phthalates due to their developmental status (Giovanoulis et al., 2018; Sathyanarayana et al., 2008; Zhu et al., 2018) .
BPA is currently used in polycarbonate plastics, found in materials intended to come into contact with food, like reusable plastic bottles, feeding-bottles, plates, cups, microwave and ovenware (Geens et al., 2009 ). In addition, we can find BPA in storage containers and epoxy resin linings for food and beverage containers. Furthermore, they are used in thermal papers and paper currencies, medical devices, dental sealants, and PCPs which are related with dermal exposure sources (Geens et al., 2012; Lv et al., 2017) . Some studies showed that BPA exposure via dermal route can highly contribute to overall internal exposure (Biedermann et al., 2010; Mielke et al., 2011) . Other studies affirm that people who work in offices will be more exposed via dust ingestion or inhalation than others because the levels of BPA in dust offices were almost 5-10 times higher than dust from particular homes (Geens et al., 2009) .
The human exposure routes to EDs are multiple (Giulivo et al., 2016) . Although the major human route of exposure to BPA and DEHP has been shown by several assessments, including the European Food Safety Authority (EFSA), to be the dietary pathway (EFSA, 2013; Geens et al., 2012; . However, some studies confirm that nondietary sources need to be more thoroughly characterized (EFSA, 2015; Geens et al., 2012) . Estimates of exposure to DEHP and BPA from all pathways along with their relative importance should be provided in order to establish which proportion of the total exposure comes from diet and which comes from non-dietary exposures. Human exposure to EDs from non-dietary sources, their toxicity, as well as their combined effects, are poorly understood (Larsson et al., 2014) .
In this study, occupational risk, lifestyle and the use of different PCPs were considered in order to assess the exposure to different pathways (dermal contact, non-dietary ingestion, and inhalation). Sharma et al. (2018) developed a P-PBPK model for BPA including specific pregnancy physiology and both oral and dermal route of exposure. The simulation results were presented to compare the reported data from different cohorts presuming the collection of samples can be from at different time points, in order to explain the inconsistency in biomonitoring data. Moreover, some authors compared the results obtained between real measurements concentrations levels of EDs in the blood reported and the exposure estimates based on PBPK models (Mielke and Gundert-Remy, 2009 ); the intake estimated were several orders of magnitude lower than the real values in blood reported in the literature. One way to explain this abnormality could be that in the PBPK model they only considered the dietary source, so this could have led to an underestimation of the exposure to these chemicals through non-dietary routes like dermal, inhalation or dust ingestion. However, there are other contributing factors for this difference such as genetic variability, biomonitoring sampling strategy and contamination of sample during analysis.
The present study aims to estimate the non-dietary (dermal, nondietary ingestion and inhalation) exposure to BPA and DEHP for a pregnant women cohort. In addition, to assess the prenatal exposure for the fetus, through all routes (diet and non-dietary), a physiologically based pharmacokinetic (PBPK) model was used. PBPK models are mathematicalrepresentations of the human body aimed at describing the timecourse distribution of chemicals in human tissues (Fàbrega et al., 2016) .In recent years, PBPK models have been used in human health risk assessmentto estimate the burdens of chemicals in human tissues, thusavoiding the analysis of this kind of samples (Fàbrega et al., , 2015 Schuhmacher et al., 2014) . The pregnancy PBPK model structure was adapted from Sharma et al. (2018) . Previous work has been extended to estimate the aggregate exposure of these EDs to humans to understand the relative importance of non-dietary exposure. Parameters and structure of the models were kept same as our previous publications (Sharma et al., 2018; Martínez et al., 2017) , except nondietary routes (inhalation and dermal) were included. The present study is in the framework of "Health and environmental-wide associations based on large population surveys" (HEALS) project (FP7-603946) and part of the study has been completed in MODELBIS project (MINECO funded with ref no AGL2016-78942-R).
Materials and methods

Study population
The study population comprises a cohort of pregnant women and ongoing birth cohort. The pregnant women were recruited during the first trimester of pregnancy as part of the European "HEALS" project. The recruitment of pregnant mothers has started in March 2016 and in the present study 72 mother-child pairs from Reus (Tarragona, Spain) were included. Women were informed of the study during their first visit (12th gestational week) to the University Hospital "Sant Joan de Reus", in Reus (Catalonia, NE Spain). Women were eligible to participate according to the following inclusion criteria: ≥ 16 years old, intention to deliver at the reference hospital, and no problems with the communication language. This study was approved by the Ethical Committee of Clinical Research of the Hospital and a written informed consent was obtained from the participants.
Questionnaires and data acquisition
At 20th gestational weeks (GW), a PCPs frequency questionnaire was filled in a face-to-face interview. Different PCPs were included in the questionnaire: a) makeup (face cream, eyeshadow and liquid foundation), b) lipstick, c) body lotion, d) shampoo, e) shower gel, f) hair conditioner, g) toothpaste, h) deodorant and i) spray perfume. In addition, the questionnaires also included in one hand, general characteristics data of the study population, such as maternal age at delivery, twin pregnancy, maternal body mass index (BMI), maternal education, social economic status, country of origin, and marital status. On the other hand, a set of questions targeting to know other sources of these compounds are included, such as maternal smoking, lifestyle, hours spend outdoors and indoors and occupational risk. A description of the characteristics of the study population is shown in The assessment of exposure of BPA and DEHP through dermal contact for pregnant women population was calculated according to Eq.
(1). We considered all PCPs previously mentioned.
( 1) where C c is the concentration of BPA or DEHP in PCPs (in µg/g); PCP fr is the frequency application (in application/day); PCP a is the amount per application (in g/application); ABS is the dermal absorption factor (non-dimensional); R f is the retention factor for rinse-off products (nondimensional); and BW 20 GW is the body weight at 20 gestational weeks (in kg). Dermal exposure is given in µg/kg bw /day. Data used to assess the dermal exposure of BPA and DEHP are summarized in Table 2 .
Non-dietary ingestion exposure
Non-dietary ingestion pathways include, on the one hand, dust ingestion that was calculated according to Eq. (2.a). On the other hand, exposure through PCPs ingestion was considered. Lipstick and toothpaste ingestion was assessed according to Eq. (2.b).
where C c is the concentration of BPA or DEHP in homes dust (in µg/kg); I r is the Ingestion rate (in kg/day) and BW 20 GW is the body weight at 20 gestational weeks (in kg). PCP fr is the frequency application (in application/day); PCP a is the amount per application (in g/application) and Ing f is the ingestion factor (non-dimensional). The total non-dietary exposure is given in µg/kg bw /day. Table 3 provides data used to assess the non-dietary ingestion exposure of BPA and DEHP.
Inhalation exposure
The exposure assessment of BPA and DEHP through inhalation for pregnant women was calculated according to equation 3. We considered levels of BPA and DEHP in the outdoor and indoor air. In this case, three different scenarios were assessed: sleeping (3.a), indoors (3.b) and outdoors (3.c) scenarios. /min); Ih r moderate is the inhalation rate during moderate activities (in m 3 /min); t sleep is the mean of time sleeping (in min); t indoor is the mean of time spending indoor (at work and at home) (in min); t outdoor is the time spending in doing activity outdoor (in min) and BW 20 GW is the body weight at 20 gestational weeks (in kg). The total inhalation exposure is given in µg/kg bw /day. Table 4 contains the data used to assess the inhalation exposure of BPA and DEHP. The concentration levels of BPA and DEHP in different PCPs, in dust and air, were taken from the literature with a preference rule of Spanish values > European values > other available data. To deal with variability and uncertainty of parameters used, probabilistic estimation of the dermal, non-dietary ingestion and inhalation exposure was performed in a probabilistic way. Monte-Carlo simulation is a common approach used to incorporate variability and uncertainty of the parameters used into the estimation of human health exposure (Mari et al., 2009; May et al., 2002; Rovira et al., 2016; Schuhmacher et al., 2001) . Tables 2-4 includes the probabilistic distribution of parameters for the calculation of human health exposure. Monte-Carlo simulation was carried out by Oracle Crystal Ball © software. Exposures were calculated based on the propagation variable of variability and uncertainty given by each parameter probability function until 100,000 iterations.
Tissue dosimetry model (PBPK)
The basic structure of pregnant PBPK model has been adapted from Sharma et al. (2018) in the current study in order to assess dietary and non-dietary exposure. It comprises plasma, liver, kidneys, fat, brain, skin, placenta, a rest of the body and a fetus compartment. Fetus compartment was subcategorized again into liver, brain, and plasma. All the Physiological parameters during pregnancy are considered to be dynamic parameters that change due to the growth of mother organs (Abduljalil et al., 2012; Gentry et al., 2003; Loccisano et al., 2013) . The source of exposure to fetuses was via a free fraction of chemicals into mother's placenta, considering that fetuses' exposure is directly related to mother's exposure. The placental-fetal unit assumes a bidirectional transfer process describing chemical transfer between mothers' placenta to fetuses' plasma and fetuses' plasma to the mothers. Detailed descriptions of standard and pregnancy-specific model equations are adapted form Sharma et al. (2018) . Metabolic kinetic parameters for both mothers and fetuses were previously estimated from in-vitro studies (Martínez et al., 2017; Sharma et al., 2018) .
Two different sources of exposure were considered for the current study, dietary exposure and the combination of dietary with nondietary exposure. The dosing considered being inputs for the PBPK model was estimated using Monte Carlo technique for the exposure assessment. It has been considered the six following exposure scenarios of BPA and DEHP: 5th percentile diet; 5th percentile diet + non-diet; Mean diet; Mean diet+ non-diet; 95th percentile diet, and 95th percentile diet + non-diet. For the current study, the routes of exposure were the following: ingestion and dermal exposure that were divided into three equal doses (with 8 h of the interval). On the other hand, continuous exposure for inhalation was presumed, considering three different inhalation rates (sleeping time, doing sedentary activities and doing moderate activities).
Results and discussion
Non-dietary (dermal, non-dietary ingestion and inhalation) exposure to BPA and DEHP
The contribution of dermal contact, non-dietary ingestion, and inhalation to the total non-dietary intake from Reus pregnant mothers' cohort was assessed in a probabilistic way using Monte-Carlo simulation. Fig. 1 , summarizes the contribution of each non-dietary source to the total exposure of BPA and DEHP. Martínez et al. Environmental Research 166 (2018) 25-34 Regarding BPA (Fig. 1) , the total non-dietary mean value was 0.002 µg/kg bw /day (0.000 and 0.004 µg/kg bw /day for 5th and 95th percentile, respectively). Relative mean contributions were 60%, 36% and 4% for non-dietary ingestion, inhalation, and dermal routes, respectively. For DEHP (Fig. 1) , the total non-dietary mean exposure was 0.597 µg/kg bw /day (0.116 µg/kg bw /day and 1.506 µg/kg bw/day for 5th and 95th percentile, respectively). The maximum mean contribution was, again, non-dietary ingestion with 81%, followed by dermal route and inhalation with 15% and 4%, respectively.
For both chemicals, BPA and DEHP, non-dietary ingestion was the highest mean relative contributor with 60% and 81%, respectively, of the total non-dietary exposure. These represented a mean non-dietary ingestion exposure of 9.62·10 −4 and 0.485 µg/kg bw /day for BPA and DEHP, respectively. Non-dietary ingestion route considered the levels of both compounds in homes dust and in PCPs that could be accidentally ingested during their use (lipstick and toothpaste). In both cases, the major contribution (> 99.9%) to the total non-dietary ingestion exposure to BPA and DEHP came from home dust ingestion. The average concentration of BPA and DEHP in dust were very high, 2·10 3 and 1.20·10 6 µg/kg dust , respectively. BPA levels in dust were obtained from Belgian houses (Geens et al., 2009 ) and phthalate levels in dust came from different European homes (Wormuth et al., 2006) . However, similar BPA and DEHP levels in indoor dust were found worldwide (Das et al., 2014; Fromme et al., 2004; Ginsberg and Belleggia, 2017; Kubwabo et al., 2016; Langer et al., 2014; Loganathan and Kannan, 2011) . The high contribution of dust in the total DEHP non-dietary ingestion exposure is due to phthalates, which are used as plasticizers in numerous consumer products, commodities, and building materials. Consequently, phthalates are found in human residential and occupational environments in high concentrations (Wormuth et al., 2006) . As well as DEHP, the high contribution of dust in the total BPA non-dietary ingestion exposure is due to BPA is used in a variety of household applications. Through manufacture and usage, these contaminants can leach into the environment and can be deposited in the indoor dust (Geens et al., 2009) . It was assumed that consumers accidentally ingest small amounts of PCPs. So, it was estimated the scenario for non-dietary LN = Log-normal; T = Triangular; U = Uniform; G = Gamma; N = Normal distribution. Mean, minimum, and maximum values were used for triangular distributions; Mean and standard deviation were used for log-normal distributions; Geometrical mean and geometrical standard deviation were used in log-normal g distributions; minimum and maximum values were used for uniform distributions; Percentile 50,95 and maximum were used in log-normal a distributions and location, scale and shape were used for gamma distribution. Environmental Research 166 (2018) [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] ingestion using information about the amounts cosmetics ingested daily (Table 3) , and the DEHP and BPA concentrations in PCP. No much information was available on how much PCPs are ingested daily and also it was not many literature data about concentration levels of these two EDs in different cosmetic products. Only data regarding DEHP in lipstick and BPA in toothpaste content were found. Therefore, it was only considered the accidental ingestion of these two cosmetics, lipstick and toothpaste, during their use. Results showed that the contribution to this kind of ingestion to the total DEHP and BPA non-dietary ingestion were insignificant (0.07% and 0.01% for BPA and DEHP, respectively) compared to total non-dietary ingestion and also with the dietary total intake. However, more bibliographic data is needed to be able to carry out a good exposure assessment. According to BPA, inhalation was the second greatest contributor to the total exposure with an exposure of 5.90·10
M.A. Martínez et al.
−4 µg/kg bw /day, that meant the 36% of the total non-dietary exposure. In this case, three different scenarios were assessed: indoor, outdoor and sleeping inhalation exposure that showed a contribution to total BPA inhalation exposure of 37%, 51%, and 12%, respectively. Inhalation exposure was lower than the dust exposure; this can be due to BPA has a comparatively low vapour pressure. As a result, concentrations of BPA in the air can be expected to be low and it will be present mainly in the particulate phase, adsorbed to dust (EFSA, 2013 (EFSA, 2013) . It must be taken into account that dermal absorption of BPA can reach 95-100% if BPA is applied dissolved in ethanol, because ethanol may act as a transport mediator for BPA into the skin, thus enhancing the absorption fraction. In addition, this property of dissolving in ethanol can be found in similar compounds in the formulation of creams and body lotions (EFSA, 2013) . Regarding DEHP, dermal contact with a mean value of 0.087 µg/ kg bw /day, was the second greatest contributor to the total non-dietary exposure (15%). In this exposure assessment, perfume and deodorant were the items which contribute more to the total DEHP dermal exposure, with 36% and 33%. The quite high presence of these ED is due to phthalates in general, are added as humectants, emollients, or skin penetration enhancers, which are very common in perfumes and fragrances (Koo and Lee, 2004) . Finally, DEHP inhalation (0.025 µg/kg bw / day) was the item which contributed less (4%) to the DEHP mean nondietary exposure. Indoor exposure and sleeping inhalation exposure had a relative contribution of 61% and 36%, respectively. Other authors (Wormuth et al., 2006) found that accidental ingestion of PCPs are the major sources of exposure to DEHP in all consumer groups that we estimated. Although the food is the dominating source of exposure to DEHP in all consumer groups (Wormuth et al., 2006) .
Indoor environment (home dust ingestion and inhalation (indoor and sleeping)) were the principal source of BPA and DEHP of nondietary exposure with a relative contribution of 78% and 85%, respectively. PCPs contribute with 4% and 15% to total mean non-dietary exposure of BPA and DEHP, respectively, almost exclusively through dermal contact. Finally, outdoor environment (trough outdoor LN = Log-normal; T = Triangular; U = Uniform. Mean, minimum, and maximum values were used for triangular distributions; Mean and standard deviation were used for log-normal distributions; Geometrical mean and geometrical standard deviation were used in log-normal g distributions; minimum and maximum values were used for uniform distributions; Mean and P95 were used for log-normal b distributions; Percentile 50 and 95 were used in log-normal c distributions.
Table 4
Monte-Carlo parameter description to assess the total inhalation contribution of BPA and DEHP. Mean, minimum, and maximum values were used for triangular distributions; Mean and standard deviation were used for log-normal distributions; Mean and P95 were used for log-normal b distributions.
inhalation) showed a contribution of 18% and < 0.1% to total mean non-dietary exposure for BPA and DEHP, respectively. Fig. 2 , shows the comparison between total dietary exposure and non-dietary (dermal, non-dietary ingestion and inhalation) exposure to BPA and DEHP. Data from the dietary exposure was previously estimated using the same cohort population (Martínez et al., 2017) .
Dietary exposure vs non-dietary exposure
Regarding BPA, mean dietary daily intake from Reus (Tarragona, Spain) cohort was 0.715 µg/kg bw /day (Martínez et al., 2017) , and the mean exposure estimated for non-dietary ingestion, inhalation, and dermal contact were 9.62·10 , 6.39·10
−5 µg/kg bw /day, respectively. In general, in the present study according to non-dietary exposure, the maximum exposure estimated for BPA was 0.0072 µg/ kg bw /day and the 95% of the population were under 0.0040 µg/kg bw / day. Non-dietary exposure practically did no contribute to the total exposure (0.2%). In other words, diet was the greatest contributor to the total exposure (99.8%) (Fig. 2) . However, it is important to know that in this study thermal paper was not considered in dermal exposure estimation, which is considered as a potential exposure source for BPA in the EU by the EFSA (2015).
BPA is conjugated in the liver by glucuronidation and sulfation, "total BPA" stands for the sum of conjugated and unconjugated forms. For further risk assessment, these two forms need to be distinguished, the unconjugated BPA is more toxicologically relevant. The contribution of dermal and inhalation sources to internal exposure to total BPA is considerably smaller compared to oral sources. However, with dermal and inhalation exposure the first-pass metabolism is lacking, regardless of the small contribution of non-dietary sources to total BPA, their contribution to the plasma concentration levels of unconjugated BPA may be considerable. Kinetic studies have shown that in monkeys only around 1% of orally absorbed BPA becomes systemically bioavailable as unconjugated BPA (Fisher et al., 2011) , whereas after dermal absorption, practically all absorbed BPA (around 10% of the external dermal dose, Demierre et al., 2012) initially becomes bioavailable as unconjugated BPA. For that reason, non-dietary sources may be of equal or even higher toxicological relevance than dietary sources Völkel et al., 2002; von Goetz et al., 2017) . Considering diet and non-diet sources the mean of the total exposure was 0.72 µg/ kg bw /day and the 5th and 95th percentile of the total exposure were 0.28 and 1.41 µg/kg bw /day (Fig. 2) .
Regarding DEHP, Fig. 2 shows that non-dietary sources contribute with 37% of the total exposure. The mean dietary daily intake of DEHP (Martínez et al., 2017) and non-dietary (dermal, non-dietary ingestion and inhalation) to BPA and DEHP for Reus pregnant women cohort. Results are given in mean (5th; 95th percentile).
exposure from Reus cohort was 1.00 µg/kg bw /day (Martínez et al., 2017) , and the mean exposure estimated for non-dietary ingestion, inhalation, and dermal contact were 0.485, 0.025, 0.087 µg/kg bw /day respectively. According to total non-dietary exposure, the maximum dose was 3.86 µg/kg bw /day and the 95th percentile was 1.51 µg/kg bw / day, and mean value was 0.60 µg/kg bw /day. Considering diet and nondiet sources the mean of the total exposure was 1.60 µg/kg bw /day and the 5th and 95th of the total exposure were 0.52 and 3.52 µg/kg bw /day, respectively (Fig. 2) .
EFSA published its comprehensive re-evaluation of BPA exposure and toxicity, in January 2015, and established a tolerable daily intake (TDI) of 4 µg/kg bw /day for BPA (EFSA, 2015) . On the other hand, EFSA and the European Chemicals Agency (ECHA) established the TDI for DEHP to 50 µg/kg bw /day (ECHA, 2010; EFSA, 2015) . Only the nondietary ingestion estimated data from this study can be compared with this EFSA and ECHA tolerable values because the TDI values are concerned about "daily intake". Therefore, in this study, the maximum value estimated for BPA non-dietary ingestion exposure was 0.0052 µg/ kg bw /day and the 95% of the population were below 0.0028 µg/kg bw / day. Whereas, for DEHP, the maximum value estimated for non-dietary ingestion exposure was 3.39 µg/kg bw /day and the 95% of the population were under 1.24 µg/kg bw /day. These values for BPA and DEHP estimated in our study were far away from the tolerable values of the EFSA and ECHA. Although BPA and DEHP non-dietary ingestion exposure assessment values were under the tolerable established, it is important to take into account that non-dietary ingestion and, in general, non-dietary levels must be added to the total dietary exposure assessment, in order to make a good exposure estimation.
Internal dosimetry
The chemicals' dose inputs considered to run the P-PBPK, were probabilistically estimated by Monte-Carlo simulation (Section 2.4). From probabilistic distribution, six total scenarios were selected for BPA and DEHP: the 5th percentile diet; the 5th percentile diet + nondiet; mean diet; mean diet + non-diet; the 95th percentile diet and the 95th percentile diet + non-diet. The outputs from the model simulation were selected considering the metabolites generated, their toxicity, gestational period and ability to reach the fetus. For this reason, only free BPA and MEHP (a metabolite of DEHP) were considered. The simulation data were taken from pregnant women and fetus for 24 h during the 24th gestational week. This period was selected because at this time fetus organs are more developed and able to incorporate right biological process. This helps us to explain the difference in metabolic processes in mothers and fetuses. Normally, at the early stage of pregnancy, for both BPA and MEHP, fetus plasma concentration level is higher due to low or no metabolic activities in the fetus (Gauderat et al., 2016; Latini et al., 2003) . In order to be near to a real scenario, a dietary, and non-dietary (dermal and ingestion) exposure were divided into three equal doses, along with continuous exposure of non-dietary source (inhalation) and were simulated (Fig. 3) in the case of BPA. On the other hand, DEHP metabolite MEHP time plasma concentration profile in case of both mother and fetus is showed in Fig. 4 , the result of single-dose intake of dietary and non-dietary. In this case, inhalation was considered again as continuous exposure, the simulated concentration curves show a sharp peak concentration o within 1 h of intake. It is known that metabolic activity in the fetus is lower compared to mother's metabolism (Heindel et al., 2017) . For that reason, concentration levels of both chemicals in the fetus' plasma were higher than in the mother. Therefore, BPA and MEHP stay longer in the fetal body, which may cause higher risk to fetuses and makes the fetus more vulnerable to the exposure. A similar trend has been observed by Sharma et al. (2018) .
Conclusions
Regarding BPA non-dietary exposure was 0.002 µg/kg bw /day, with the greatest contribution coming from non-dietary ingestion with 60%, followed by inhalation with 36%. Finally, dermal exposure was the one that contributed the least with 4%. However, in this study, the thermal paper was not considered in dermal exposure estimation, which is considered as a potential exposure source for the general population (EFSA, 2015) . According to DEHP non-dietary exposure (0.597 µg/ kg bw /day), the maximum contributor was non-dietary ingestion with 81%, followed by dermal contact with 15% and inhalation with 4%. As expected, diet was the main contributor to total exposure to both chemicals. Regarding DEHP, non-dietary sources contribute 37% of the total exposure. The non-dietary exposure to BPA practically did no contribute to the total exposure (0.22%). Indoor environment, dust ingestion, and indoor air inhalation was the main contributor to nondietary exposure to both ED (78% for BPA and 85% for DEHP) meanwhile PCPs contribute in 4% and 15%, for BPA and DEHP, respectively. However, with dermal absorption that passes the first-pass metabolism, dermal sources may be of equal or even higher toxicological relevance than dietary sources (Völkel et al., 2002; von Goetz et al., 2017) . Only the non-dietary ingestion estimated data in combination with other dietary exposure from this study can be comparable with EFSA and Fig. 3 . Time versus BPA plasma concentration for mothers a), and fetuses b), considering six different exposure scenarios (the 5th percentile diet; the 5th percentile diet + non-diet; mean diet; mean diet + non-diet; the 95th percentile diet and the 95th percentile diet + non-diet). It was considered threefood intake dose for diet and non-diet (dermal and dust ingestion) keeping inhalation as a continuous exposure.
ECHA tolerable values because the TDI values are concerned about "daily intake". Although BPA and DEHP non-dietary ingestion exposure assessment values were under the tolerable established, it is important to take into account that non-dietary exposure levels must be added to the total dietary exposure assessment, in order to make a good exposure estimation.
According to internal dosimetry, six different scenarios were considered in order to run the PBPK model. When the simulation considered diet + non-diet scenarios, the concentration levels of BPA and MEHP (main metabolite of DEHP) increased considerably in plasma. In addition, in fetus' plasma, the concentration of both chemicals reached levels much higher than those seen previously in mothers. The low metabolic activity in fetus led to maintain a continuous concentration in time. Therefore, this can make the fetus more vulnerable to the exposure compared with their mothers.
The ongoing research is to validate the PBPK model with biological samples from this cohort and demonstrate that this methodology allows the determination of BPA and MEHP for monitoring in biological matrices, such as plasma and urine. Finally, demonstrate that PBPK model can predict the prenatal exposure of the child/fetus to EDs. To conclude, on the one hand, strategies must be presented in order to reduce their exposure. Restrictions must be imposed to regulate the production and use of products related especially with childcare and pregnant women. Fig. 4 . Time versus MEHP plasma concentration for mothers c) and fetuses d), considering six different exposure scenarios (the 5th percentile diet; the 5th percentile diet + non-diet; mean diet; mean diet + non-diet; the 95th percentile diet and the 95th percentile diet + non-diet). It was considered onefood intake dose for diet and non-diet (dermal and dust ingestion) keeping inhalation as a continuous exposure.
